Adrenocortical Dysplasia Homolog (ACD) (Middle Region) Peptide
Quick Overview for Adrenocortical Dysplasia Homolog (ACD) (Middle Region) Peptide (ABIN972807)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-ACD antibody (Catalog #: ARP58253_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ACD (Adrenocortical Dysplasia Homolog (ACD))
-
Background
-
ACD is a protein that is involved in telomere function. This protein is one of six core proteins in the telosome/shelterin telomeric complex, which functions to maintain telomere length and to protect telomere ends. Through its interaction with other comp
Alias Symbols: PIP1, PTOP, TINT1, TPP1
Protein Interaction Partner: POT1,TINF2,LLGL1,POT1,TINF2,USP7,XRCC6,POT1,TERF1,TINF2,XRCC6
Protein Size: 544 -
Molecular Weight
- 58 kDa
-
Gene ID
- 65057
-
NCBI Accession
- NM_001082486, NP_001075955
-
UniProt
- Q96AP0
Target
-